
PhnyX Lab provides Cheiron, an AI platform that helps biopharma teams find, verify, and act on fragmented research, clinical, and regulatory intelligence faster. The company is a B2B SaaS provider using AI and GenAI to unify literature, clinical trials, regulatory filings, and patents into a single, traceable knowledge layer. Cheiron delivers specialized retrieval models, automated workflow generation, source credibility scoring, and provenance tracking to improve fact accuracy and reduce time spent on documentation and literature review. The platform is built for researchers, clinical teams, and regulatory specialists at pharmaceutical and biotech companies to accelerate discovery and regulatory decision-making at scale.

PhnyX Lab provides Cheiron, an AI platform that helps biopharma teams find, verify, and act on fragmented research, clinical, and regulatory intelligence faster. The company is a B2B SaaS provider using AI and GenAI to unify literature, clinical trials, regulatory filings, and patents into a single, traceable knowledge layer. Cheiron delivers specialized retrieval models, automated workflow generation, source credibility scoring, and provenance tracking to improve fact accuracy and reduce time spent on documentation and literature review. The platform is built for researchers, clinical teams, and regulatory specialists at pharmaceutical and biotech companies to accelerate discovery and regulatory decision-making at scale.